新型冠状病毒感染后继发肺部感染的病原学特征及危险因素分析
Pathological Characteristics and Risk Factors of Secondary Pulmonary Infections following COVID-19 Infection
DOI: 10.12677/acm.2025.153667, PDF,   
作者: 李昊楠, 喻昌利*:华北理工大学附属医院,呼吸与危重症二科,河北 唐山
关键词: 新型冠状病毒感染继发感染病原学COVID-19 Infection Secondary Infection Etiology
摘要: 目的:研究新型冠状病毒感染患者继发肺部感染的危险因素及病原学特征。方法:选取2023年1月~2025年1月就诊于华北理工大学附属医院呼吸科及重症医学科住院治疗的新型冠状病毒感染患者为研究对象。选择其中继发肺部感染的患者作为病例组,未继发肺部感染的患者为对照组。根据患者病历收集临床资料,分析病例组常见病原菌分布情况,比较病例组和对照组各项指标,采用条件Logistic回归分析研究新型冠状病毒继发肺部感染的危险因素。结果:84例感染组患者中,痰培养共检出病原菌94株,其中革兰氏阴性菌55株,革兰氏阴性菌15株,真菌24株。白细胞绝对值、CRP、PCT、白蛋白数值、氧分压以及氧合指数是独立危险因素。结论:新型冠状病毒继发肺部感染患者常见病原菌为革兰氏阴性菌,其次为真菌。白细胞绝对值、CRP、PCT、白蛋白数值、氧分压以及氧合指数是新型冠状病毒感染后继发肺部感染的独立危险因素。
Abstract: Purpose: To study the risk factors and etiological characteristics of secondary pulmonary infection in patients infected with the novel coronavirus. Methods: Patients infected with the novel coronavirus who were hospitalized in the Department of Respiratory Medicine and Department of Critical Care Medicine of Affiliated Hospital of North China University of Science and Technology from January 2023 to January 2025 were selected as the study subjects. Patients with secondary pulmonary infection were assigned to the case group, while those without secondary pulmonary infection were assigned to the control group. Clinical data were collected from the medical records of the patients. The distribution of common pathogens in the case group was analyzed, and various indicators were compared between the case and control groups. Conditional Logistic regression analysis was used to study the risk factors for secondary pulmonary infection following novel coronavirus infection. Results: Among the 84 patients with infection, sputum cultures detected a total of 94 strains of pathogens, including 55 strains of Gram-negative bacteria, 15 strains of Gram-positive bacteria, and 24 strains of fungi. The absolute value of white blood cells, CRP, PCT, albumin levels, partial pressure of oxygen, and oxygenation index were identified as independent risk factors. Conclusion: The common pathogens in patients with secondary pulmonary infection following novel coronavirus infection are Gram-negative bacteria, followed by fungi. The absolute value of white blood cells, CRP, PCT, albumin levels, partial pressure of oxygen, and oxygenation index are independent risk factors for secondary pulmonary infection following novel coronavirus infection.
文章引用:李昊楠, 喻昌利. 新型冠状病毒感染后继发肺部感染的病原学特征及危险因素分析[J]. 临床医学进展, 2025, 15(3): 696-703. https://doi.org/10.12677/acm.2025.153667

参考文献

[1] World Health Organization (2023) WHO Coronavirus (COVID-19) Dashboard.
[2] Wang, C., Horby, P.W., Hayden, F.G. and Gao, G.F. (2020) A Novel Coronavirus Outbreak of Global Health Concern. The Lancet, 395, 470-473. [Google Scholar] [CrossRef] [PubMed]
[3] Gorbalenya, A.E., Baker, S.C., Baric, R.S., de Groot, R.J., Drosten, C., Gulyaeva, A.A., et al. (2020) The Species Severe Acute Respiratory Syndrome-Related Coronavirus: Classifying 2019-nCoV and Naming It SARS-CoV-2. Nature Microbiology, 5, 536-544. [Google Scholar] [CrossRef] [PubMed]
[4] 新型冠状病毒感染诊疗方案(试行第十版) [J]. 传染病信息, 2023(36): 18-25.
[5] Garcia-Vidal, C., Sanjuan, G., Moreno-García, E., Puerta-Alcalde, P., Garcia-Pouton, N., Chumbita, M., et al. (2021) Incidence of Co-Infections and Superinfections in Hospitalized Patients with COVID-19: A Retrospective Cohort Study. Clinical Microbiology and Infection, 27, 83-88. [Google Scholar] [CrossRef] [PubMed]
[6] Xu, Z., Shi, L., Wang, Y., Zhang, J., Huang, L., Zhang, C., et al. (2020) Pathological Findings of COVID-19 Associated with Acute Respiratory Distress Syndrome. The Lancet Respiratory Medicine, 8, 420-422. [Google Scholar] [CrossRef] [PubMed]
[7] Westblade, L.F., Simon, M.S. and Satlin, M.J. (2021) Bacterial Coinfections in Coronavirus Disease 2019. Trends in Microbiology, 29, 930-941. [Google Scholar] [CrossRef] [PubMed]
[8] Lu, S., Li, T., Xi, X., Chen, Q., Liu, X., Zhang, B., et al. (2014) Prognosis of 18 H7N9 Avian Influenza Patients in Shanghai. PLOS ONE, 9, e88728. [Google Scholar] [CrossRef] [PubMed]
[9] 孔诚, 陈晖, 苏晓聪, 等. 重症新型冠状病毒患者合并细菌真菌感染流行病学调查[J]. 医药前沿, 2024, 14(4): 128-131.
[10] Kubin, C.J., McConville, T.H., Dietz, D., Zucker, J., May, M., Nelson, B., et al. (2021) Characterization of Bacterial and Fungal Infections in Hospitalized Patients with Coronavirus Disease 2019 and Factors Associated with Health Care-Associated Infections. Open Forum Infectious Diseases, 8, ofab201. [Google Scholar] [CrossRef] [PubMed]
[11] Yang, Z., Liu, J., Zhou, Y., Zhao, X., Zhao, Q. and Liu, J. (2020) The Effect of Corticosteroid Treatment on Patients with Coronavirus Infection: A Systematic Review and Meta-Analysis. Journal of Infection, 81, e13-e20. [Google Scholar] [CrossRef] [PubMed]
[12] Hraiech, S., Ladjal, K., Guervilly, C., Hyvernat, H., Papazian, L., Forel, J.M., et al. (2023) Lung Abscess Following Ventilator-Associated Pneumonia during COVID-19: A Retrospective Multicenter Cohort Study. Critical Care, 27, Article No. 385. [Google Scholar] [CrossRef] [PubMed]
[13] Hoenigl, M., Seidel, D., Sprute, R., Cunha, C., Oliverio, M., Goldman, G.H., et al. (2022) COVID-19-Associated Fungal Infections. Nature Microbiology, 7, 1127-1140. [Google Scholar] [CrossRef] [PubMed]
[14] The RECOVERY Collaborative Group (2021) Dexamethasone in Hospitalized Patients with COVID-19. New England Journal of Medicine, 384, 693-704. [Google Scholar] [CrossRef] [PubMed]
[15] Langford, B.J., So, M., Raybardhan, S., Leung, V., Soucy, J.R., Westwood, D., et al. (2021) Antibiotic Prescribing in Patients with COVID-19: Rapid Review and Meta-Analysis. Clinical Microbiology and Infection, 27, 520-531. [Google Scholar] [CrossRef] [PubMed]
[16] Grasselli, G., Scaravilli, V., Mangioni, D., Scudeller, L., Alagna, L., Bartoletti, M., et al. (2021) Hospital-Acquired Infections in Critically Ill Patients with COVID-19. Chest, 160, 454-465. [Google Scholar] [CrossRef] [PubMed]
[17] Calderon, M., Gysin, G., Gujjar, A., McMaster, A., King, L., Comandé, D., et al. (2023) Bacterial Co-Infection and Antibiotic Stewardship in Patients with COVID-19: A Systematic Review and Meta-Analysis. BMC Infectious Diseases, 23, 14-29. [Google Scholar] [CrossRef] [PubMed]
[18] Puzniak, L., Bauer, K.A., Yu, K.C., Moise, P., Finelli, L., Ye, G., et al. (2021) Effect of Inadequate Empiric Antibacterial Therapy on Hospital Outcomes in SARS-CoV-2-Positive and-Negative US Patients with a Positive Bacterial Culture: A Multicenter Evaluation from March to November 2020. Open Forum Infectious Diseases, 8, 232-248. [Google Scholar] [CrossRef] [PubMed]